30 Apr 2025

Why Pharmacovigilance Data Quality Matters

2025-05-06T14:23:21+02:00April 30, 2025|All, HEOR Insights|

In pharmacovigilance, high-quality data isn’t just about meeting regulatory checkboxes, it’s a vital cornerstone in protecting patient safety.

When pharmacovigilance falls short, the repercussions can be severe, from misleading safety statistics to, in the worst cases, preventable harm or even death. […]

14 Jan 2025

Real-world evidence (RWE) and Clinical Trials: Complementary roles in evidence- based research for all patients

2025-01-14T10:51:47+01:00January 14, 2025|All, HEOR Insights|

Certain patient groups may be underrepresented or excluded from RCTs due to eligibility criteria, logistical barriers, ethical concerns or other reasons.

Examples of these potential groups are females, pregnant or breastfeeding females, older adults due to age or comorbidities, children, people […]

Go to Top